-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Observations on patents and other IP from a dual-licensed practitioner
James Meigs has a piece in the newest edition of Commentary entitled "Thank God For Big Pharma". It doesn't say anything that's not already familiar to people involved in the…
The Israel Embassy in Geneva has organized a webinar that will take place on May 7 at 16:00 Israel time (09:00 Eastern time in the US). The main speaker will…
After last week's fanfare (in Israel, anyway) about the Israeli government exercising rights under section 104 of the patent statute to allow importation of a generic of Abbvie's Kaletra tablets,…
As I mentioned yesterday, the Minister of Health signed an order this week allowing the state to import generic Kaletra (a combination of lopinavir and ritonavir) to be used, potentially,…
The Israel Patent Statute was enacted in 1967. Despite being amended several times since then, most recently in 2012, it has always contained two provisions to enable third parties to…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.
America-Israel Patent Law Blog 